Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of VT7208 in healthy participants and individuals with Multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• VT7208 (VT7208)

Snippet

Sponsor: Vidya Therapeutics Inc | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: RECRUITING